Drug
Rotigotine PR 2 1 4
Rotigotine PR 2 1 4: highest development phase Phase 1, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rotigotine PR 2.1.4 NCT01565018 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Rotigotine PR 2 1 4 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.